Lv1
30 积分 2025-12-12 加入
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
10天前
已完结
An Enhanced Treatment Algorithm Targeting Mucosal Healing is Effective and Safe in Older Patients with Crohn’s Disease: A Post-hoc Analysis of the REACT2 Trial
10天前
已关闭
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
10天前
已完结
Comparative study of adalimumab versus conventional therapy in sight-threatening refractory Behçet’s uveitis with vasculitis
25天前
已完结
Adalimumab Monotherapy and a Combination with Azathioprine for Crohn’s Disease: A Prospective, Randomized Trial
27天前
已完结
Intensive drug therapy versus standard drug therapy for symptomatic intestinal Crohn's disease strictures (STRIDENT): an open-label, single-centre, randomised controlled trial
1个月前
已完结
Real-world Short-term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Multicenter, Prospective Study in China
1个月前
已完结
Efficacy and safety of intravenous induction and subcutaneous maintenance therapy with guselkumab for patients with Crohn's disease (GALAXI-2 and GALAXI-3): 48-week results from two phase 3, randomised, placebo and active comparator-controlled, double-blind, triple-dummy trials
1个月前
已完结
Reframing Immune-Mediated Inflammatory Diseases through Signature Cytokine Hubs
1个月前
已完结
Beitrag zur Leberfunktionsprobe nach Felix
3个月前
已完结
皖公网安备34019202002308
